$ALMS
ALUMIS INC.

2024 Q3 Form 10-Q Financial Statement

#000184736724000005 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.58M
YoY Change
% of Gross Profit
Research & Development $87.82M $37.79M
YoY Change 132.41%
% of Gross Profit
Depreciation & Amortization $814.0K
YoY Change
% of Gross Profit
Operating Expenses $98.40M $43.76M
YoY Change 124.87%
Operating Profit -$98.40M -$43.76M
YoY Change 124.87%
Interest Expense $5.322M
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.282M $382.0K
YoY Change 1282.72%
Pretax Income -$93.12M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$93.12M -$43.38M
YoY Change 114.67%
Net Earnings / Revenue
Basic Earnings Per Share -$1.73 -$19.76
Diluted Earnings Per Share -$1.73 -$19.76
COMMON SHARES
Basic Shares Outstanding 53.75M 2.195M
Diluted Shares Outstanding 53.75M 2.195M

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $361.9M
YoY Change
Cash & Equivalents $213.4M $53.94M
Short-Term Investments $148.5M
Other Short-Term Assets $15.11M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $377.3M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $21.43M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.000K
YoY Change
Total Long-Term Assets $35.21M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $377.3M
Total Long-Term Assets $35.21M
Total Assets $412.6M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.444M
YoY Change
Accrued Expenses $27.07M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $33.52M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $30.66M
YoY Change
Total Long-Term Liabilities $30.66M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $33.52M
Total Long-Term Liabilities $30.66M
Total Liabilities $64.17M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$563.8M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $348.4M -$303.1M
YoY Change
Total Liabilities & Shareholders Equity $412.6M
YoY Change

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$93.12M -$43.38M
YoY Change 114.67%
Depreciation, Depletion And Amortization $814.0K
YoY Change
Cash From Operating Activities -$83.77M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $779.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$92.41M
YoY Change
Cash From Investing Activities -$93.19M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 235.2M
YoY Change
NET CHANGE
Cash From Operating Activities -83.77M
Cash From Investing Activities -93.19M
Cash From Financing Activities 235.2M
Net Change In Cash 58.20M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$83.77M
Capital Expenditures $779.0K
Free Cash Flow -$84.54M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001847367
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2023Q3 alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2024Q3 alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2023Q3 alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2024Q3 alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2023Q3 alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2024Q3 alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2023Q3 alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2024Q3 alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2139
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2139
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42143
dei Entity Registrant Name
EntityRegistrantName
Alumis Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1771129
dei Entity Address Address Line1
EntityAddressAddressLine1
280 East Grand Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
231-6625
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ALMS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213417000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45996000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
113000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
148453000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2956000
CY2024Q3 alms Research And Development Prepaid Expenses
ResearchAndDevelopmentPrepaidExpenses
12241000
CY2023Q4 alms Research And Development Prepaid Expenses
ResearchAndDevelopmentPrepaidExpenses
2661000
CY2024Q3 alms Other Prepaid Expense And Assets Current
OtherPrepaidExpenseAndAssetsCurrent
3236000
CY2023Q4 alms Other Prepaid Expense And Assets Current
OtherPrepaidExpenseAndAssetsCurrent
1631000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
377347000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
53357000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21429000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22441000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12752000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12783000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2024Q3 us-gaap Assets
Assets
412559000
CY2023Q4 us-gaap Assets
Assets
89612000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6444000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1118000
CY2024Q3 alms Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
18140000
CY2023Q4 alms Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
10946000
CY2024Q3 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7464000
CY2023Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7087000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1467000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1720000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
33515000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20871000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29631000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30860000
CY2024Q3 alms Share Repurchase Liability
ShareRepurchaseLiability
1024000
CY2023Q4 alms Share Repurchase Liability
ShareRepurchaseLiability
1771000
CY2024Q3 us-gaap Liabilities
Liabilities
64170000
CY2023Q4 us-gaap Liabilities
Liabilities
53502000
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
89016578
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2024Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
85960088
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
85960088
CY2024Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2023Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
370540000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
912037000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25055000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
139000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563792000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364318000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
348389000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-339260000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
412559000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89612000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87824000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37788000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178350000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
103071000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10575000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5971000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23782000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14971000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
98399000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
43759000
us-gaap Operating Expenses
OperatingExpenses
202132000
us-gaap Operating Expenses
OperatingExpenses
118042000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-98399000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-43759000
us-gaap Operating Income Loss
OperatingIncomeLoss
-202132000
us-gaap Operating Income Loss
OperatingIncomeLoss
-118042000
CY2024Q3 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
5322000
CY2023Q3 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
951000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
8153000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
2509000
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-551000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5406000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-119000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-89000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5282000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
382000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2658000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2349000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-93117000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43377000
us-gaap Net Income Loss
NetIncomeLoss
-199474000
us-gaap Net Income Loss
NetIncomeLoss
-115693000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
140000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
137000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
127000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92977000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43380000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-199337000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115566000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.76
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-54.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-54.98
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53752223
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53752223
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2194988
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2194988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19647690
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19647690
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2104282
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2104282
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
85960088
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-339260000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2024Q1 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
494000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
6000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2657000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-49849000
CY2024Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
127224979
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
495575000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-385926000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
287000
CY2024Q2 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
253000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
6000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3133000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-56508000
CY2024Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
168489871
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
639237000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-438755000
CY2024Q3 alms Conversion And Redesignation Of Temporary Equity Shares
ConversionAndRedesignationOfTemporaryEquityShares
-168489871
CY2024Q3 alms Conversion And Redesignation Of Temporary Equity Amount
ConversionAndRedesignationOfTemporaryEquityAmount
-639237000
CY2024Q3 alms Conversion And Redesignation Of Temporary Equity Into Permanent Equity Amount
ConversionAndRedesignationOfTemporaryEquityIntoPermanentEquityAmount
639237000
CY2024Q3 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
201000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
4000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7309000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
140000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-93117000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
348389000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
67960088
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
285473000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-195242000
CY2023Q1 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
694000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
5000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1831000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
100000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-36027000
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
67960088
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
285473000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-228639000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
CY2023Q2 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
559000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
6000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1909000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
30000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-36289000
CY2023Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
79960088
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
343152000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-262353000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2023Q3 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
362000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
6000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2270000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43377000
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
79960088
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
343152000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-303072000
us-gaap Profit Loss
ProfitLoss
-199474000
us-gaap Profit Loss
ProfitLoss
-115693000
us-gaap Share Based Compensation
ShareBasedCompensation
13099000
us-gaap Share Based Compensation
ShareBasedCompensation
6010000
alms Non Cash Lease Expense
NonCashLeaseExpense
31000
alms Non Cash Lease Expense
NonCashLeaseExpense
1975000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2332000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
558000
alms Accretion Expense Net Of Discounts On Marketable Securities
AccretionExpenseNetOfDiscountsOnMarketableSecurities
-1987000
alms Accretion Expense Net Of Discounts On Marketable Securities
AccretionExpenseNetOfDiscountsOnMarketableSecurities
-524000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-266000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5406000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-119000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-645000
alms Increase Decrease In Research And Development Prepaid Expenses
IncreaseDecreaseInResearchAndDevelopmentPrepaidExpenses
9581000
alms Increase Decrease In Research And Development Prepaid Expenses
IncreaseDecreaseInResearchAndDevelopmentPrepaidExpenses
-3605000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1605000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
150000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5322000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2645000
alms Increase Decrease In Research And Development Accrued Expenses
IncreaseDecreaseInResearchAndDevelopmentAccruedExpenses
7193000
alms Increase Decrease In Research And Development Accrued Expenses
IncreaseDecreaseInResearchAndDevelopmentAccruedExpenses
3342000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
426000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
864000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1481000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
90000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180314000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96248000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
42000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76250000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
185374000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8345000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1366000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3289000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144740000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
64616000
alms Proceeds From Issuance Of Redeemable Convertible Preferred Stock And Derivative Liability Net Of Issuance Costs
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockAndDerivativeLiabilityNetOfIssuanceCosts
258461000
alms Proceeds From Issuance Of Redeemable Convertible Preferred Stock And Derivative Liability Net Of Issuance Costs
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockAndDerivativeLiabilityNetOfIssuanceCosts
59791000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
193316000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
-10000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
40000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
591000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
241000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
64000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
492362000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59958000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
167308000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
28326000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47133000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26954000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214441000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55280000
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
168489871
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
639237000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14255000
alms Property And Equipment Acquired Through Tenant Improvement
PropertyAndEquipmentAcquiredThroughTenantImprovement
16641000
alms Vesting Of Exercised Stock Options And Restricted Shares Of Common Stock
VestingOfExercisedStockOptionsAndRestrictedSharesOfCommonStock
964000
alms Vesting Of Exercised Stock Options And Restricted Shares Of Common Stock
VestingOfExercisedStockOptionsAndRestrictedSharesOfCommonStock
1632000
alms Purchases Of Property And Equipment In Other Accrued Expenses And Liabilities
PurchasesOfPropertyAndEquipmentInOtherAccruedExpensesAndLiabilities
6000
alms Purchases Of Property And Equipment In Other Accrued Expenses And Liabilities
PurchasesOfPropertyAndEquipmentInOtherAccruedExpensesAndLiabilities
960000
alms Recognition Of Derivative Liability Upon Issuance Of Convertible Preferred Stock
RecognitionOfDerivativeLiabilityUponIssuanceOfConvertiblePreferredStock
8913000
alms Recognition Of Derivative Liability Upon Issuance Of Convertible Preferred Stock
RecognitionOfDerivativeLiabilityUponIssuanceOfConvertiblePreferredStock
2112000
alms Settlement Of Derivative Liability Upon Issuance Of Redeemable Convertible Preferred Stock
SettlementOfDerivativeLiabilityUponIssuanceOfRedeemableConvertiblePreferredStock
14319000
alms Deferred Offering Cost In Accounts Payable And Accrued Expenses Current Liabilities
DeferredOfferingCostInAccountsPayableAndAccruedExpensesCurrentLiabilities
544000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213417000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53937000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
319000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214441000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55280000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-93100000
us-gaap Net Income Loss
NetIncomeLoss
-199500000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43400000
us-gaap Net Income Loss
NetIncomeLoss
-115700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96200000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563800000
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
361900000
CY2024Q1 alms Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected within these condensed consolidated financial statements include, but are not limited to, the fair value of the Company’s common stock and redeemable convertible preferred stock, the fair value of the derivative liability, stock-based compensation expense, accruals for research and development expenses and the valuation of deferred tax assets. The Company bases its estimates on known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates, as there are changes in circumstances, facts and experience. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from those estimates.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, investments in marketable securities and restricted cash. The Company maintains bank deposits in federally insured financial institutions and these deposits exceed federally insured limits. To date, the Company has not experienced any losses on its deposits of cash and periodically evaluates the creditworthiness of financial institutions at which bank deposits are maintained.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also invests in money market funds and U.S. treasuries, which are subject to certain credit risks. The Company mitigates the risks by investing in high-grade instruments, limiting its exposure to any one issuer and monitoring the ongoing creditworthiness of the financial institutions and issuers. The Company has not experienced any loss of principal on its financial instruments.</p>
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
8913000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
2112000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5406000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-119000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
14319000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2231000
CY2024Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
148315000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
138000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148453000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
2954000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2956000
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
CY2023Q3 alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
CY2024Q3 alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
952000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
111000
CY2024Q3 alms Prepaid Subscriptions Current
PrepaidSubscriptionsCurrent
896000
CY2023Q4 alms Prepaid Subscriptions Current
PrepaidSubscriptionsCurrent
703000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
767000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
108000
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
364000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
614000
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
257000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
95000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3236000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1631000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25165000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23849000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3736000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1408000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21429000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22441000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
800000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2300000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
600000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5396000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5585000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1991000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1093000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
77000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
409000
CY2024Q3 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7464000
CY2023Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7087000
CY2021Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
14000
CY2023Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-600000
CY2022Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
12000
CY2022Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
55000
CY2023Q4 us-gaap Incentive To Lessee
IncentiveToLessee
17200000
CY2022 alms Proceeds From Tenant Improvement Allowance Received
ProceedsFromTenantImprovementAllowanceReceived
500000
CY2023 alms Proceeds From Tenant Improvement Allowance Received
ProceedsFromTenantImprovementAllowanceReceived
16700000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
37900000
CY2023Q1 alms Lessee Operating Lease Liability Gross Fixed Payment
LesseeOperatingLeaseLiabilityGrossFixedPayment
54600000
CY2023Q1 alms Lessee Operating Lease Incentive Receivable Current
LesseeOperatingLeaseIncentiveReceivableCurrent
16700000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14100000
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2022Q3 alms Lessee Operating Lease Incentive Receivable Current
LesseeOperatingLeaseIncentiveReceivableCurrent
16700000
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2024Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000.0
CY2023Q4 alms Number Of Letter Of Credits On Lease Held
NumberOfLetterOfCreditsOnLeaseHeld
2
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1100000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
882000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1279000
us-gaap Operating Lease Cost
OperatingLeaseCost
2593000
us-gaap Operating Lease Cost
OperatingLeaseCost
3830000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
297000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
214000
us-gaap Variable Lease Cost
VariableLeaseCost
953000
us-gaap Variable Lease Cost
VariableLeaseCost
330000
CY2024Q3 us-gaap Lease Cost
LeaseCost
1179000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1493000
us-gaap Lease Cost
LeaseCost
3546000
us-gaap Lease Cost
LeaseCost
4160000
us-gaap Operating Lease Payments
OperatingLeasePayments
4076000
us-gaap Operating Lease Payments
OperatingLeasePayments
1740000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1223000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4959000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5125000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5296000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5474000
CY2024Q3 alms Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
27515000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
49592000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18494000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31098000
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2100000
CY2023Q4 alms Derivative Liability Amount Reclassified To Temporary Equity
DerivativeLiabilityAmountReclassifiedToTemporaryEquity
2200000
CY2024Q1 alms Number Of Freestanding Financial Instruments
NumberOfFreestandingFinancialInstruments
2
CY2024Q1 alms Fair Value Of Freestanding Financial Instruments
FairValueOfFreestandingFinancialInstruments
8900000
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
89016578
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
85960088
CY2023Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
370540000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
alms Number Of Days Prior Notice To Increase Or Decrease Interest Threshold Limit
NumberOfDaysPriorNoticeToIncreaseOrDecreaseInterestThresholdLimit
P61D
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17095644
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
23779443
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.84
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.23
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4603443
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.84
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
700000
CY2024Q1 alms Share Based Payment Arrangement Plan Modification Incremental Cost Associated With Vested Options
ShareBasedPaymentArrangementPlanModificationIncrementalCostAssociatedWithVestedOptions
100000
CY2024Q1 alms Share Based Payment Arrangement Plan Modification Incremental Cost Associated With Unvested Options
ShareBasedPaymentArrangementPlanModificationIncrementalCostAssociatedWithUnvestedOptions
600000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.50
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
71662
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25506
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7309000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2270000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13099000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6010000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7309000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2270000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13099000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6010000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-93117000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43377000
us-gaap Net Income Loss
NetIncomeLoss
-199474000
us-gaap Net Income Loss
NetIncomeLoss
-115693000
CY2024Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
53970560
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2650252
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
19908040
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2640771
CY2024Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
218337
CY2023Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
455264
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
260350
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
536489
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53752223
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53752223
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2194988
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2194988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19647690
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19647690
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2104282
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2104282
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.76
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-54.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-54.98
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8878493
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22198949
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2024Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001847367-24-000005-index-headers.html Edgar Link pending
0001847367-24-000005-index.html Edgar Link pending
0001847367-24-000005.txt Edgar Link pending
0001847367-24-000005-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240930.xsd Edgar Link pending
tmb-20240930x10q.htm Edgar Link pending
tmb-20240930xex31d1.htm Edgar Link pending
tmb-20240930xex31d2.htm Edgar Link pending
tmb-20240930xex32d1.htm Edgar Link pending
tmb-20240930xex32d2.htm Edgar Link pending
tmb-20240930_cal.xml Edgar Link unprocessable
tmb-20240930_def.xml Edgar Link unprocessable
tmb-20240930_lab.xml Edgar Link unprocessable
tmb-20240930_pre.xml Edgar Link unprocessable
tmb-20240930x10q_htm.xml Edgar Link completed